OBJECTIVE: To examine the association between plasma resistin levels and the presence of coronary heart disease (CHD) in women. RESEARCH METHODS AND PROCEDURES: Plasma resistin levels were measured in a case-control study including 185 women with angiographically confirmed CHD and 227 population-based female controls from the Coronary Risk Factors for Atherosclerosis in Women (CORA) study. RESULTS: After adjustment for age, smoking, family history of myocardial infarction, retirement, education, physical activity, menopausal status, hormone replacement use, BMI, hypertension, diabetes, and dyslipidemia, the odds ratio for CHD for women in the highest compared with lowest quintile of plasma resistin levels was 3.19 (95% confidence interval, 1.44 to 7.10; p log trend, 0.001). After additional adjustment for plasma C-reactive protein levels, this association was substantially attenuated and no longer significant (odds ratio, 1.80; 95% confidence interval, 0.69 ti 4.69; p trend = 0.23). DISCUSSION: These results suggest that plasma resistin levels are significantly associated with the presence of CHD in women; however, this association can largely be explained by concomitant inflammatory processes. Further studies are needed to determine the causal role of resistin in the development of CHD in humans.
OBJECTIVE: To examine the association between plasma resistin levels and the presence of coronary heart disease (CHD) in women. RESEARCH METHODS AND PROCEDURES: Plasma resistin levels were measured in a case-control study including 185 women with angiographically confirmed CHD and 227 population-based female controls from the Coronary Risk Factors for Atherosclerosis in Women (CORA) study. RESULTS: After adjustment for age, smoking, family history of myocardial infarction, retirement, education, physical activity, menopausal status, hormone replacement use, BMI, hypertension, diabetes, and dyslipidemia, the odds ratio for CHD for women in the highest compared with lowest quintile of plasma resistin levels was 3.19 (95% confidence interval, 1.44 to 7.10; p log trend, 0.001). After additional adjustment for plasma C-reactive protein levels, this association was substantially attenuated and no longer significant (odds ratio, 1.80; 95% confidence interval, 0.69 ti 4.69; p trend = 0.23). DISCUSSION: These results suggest that plasma resistin levels are significantly associated with the presence of CHD in women; however, this association can largely be explained by concomitant inflammatory processes. Further studies are needed to determine the causal role of resistin in the development of CHD in humans.
Authors: Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Pina Elvira Russo; Lucia Riegler; Renatomaria Bianchi; Mario Crisci; Gaetano Di Palma; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò Journal: World J Cardiol Date: 2014-07-26
Authors: Gökhan Aksan; Sinan İnci; Gökay Nar; Korhan Soylu; Ömer Gedikli; Serkan Yüksel; Metin Özdemir; Rukiye Nar; Murat Meriç; Mahmut Şahin Journal: Int J Clin Exp Med Date: 2014-12-08
Authors: W Q Fang; Q Zhang; Y B Peng; M Chen; X P Lin; J H Wu; C H Cai; Y F Mei; H Jin Journal: J Endocrinol Invest Date: 2010-07-29 Impact factor: 4.256
Authors: Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter Journal: Clin Sci (Lond) Date: 2019-11-29 Impact factor: 6.124
Authors: Baris Gencer; Reto Auer; Nathalie de Rekeneire; Javed Butler; Andreas Kalogeropoulos; Douglas C Bauer; Stephen B Kritchevsky; Iva Miljkovic; Eric Vittinghoff; Tamara Harris; Nicolas Rodondi Journal: Atherosclerosis Date: 2015-12-09 Impact factor: 5.162
Authors: Qibin Qi; Claudia Menzaghi; Shelly Smith; Liming Liang; Nathalie de Rekeneire; Melissa E Garcia; Kurt K Lohman; Iva Miljkovic; Elsa S Strotmeyer; Steve R Cummings; Alka M Kanaya; Frances A Tylavsky; Suzanne Satterfield; Jingzhong Ding; Eric B Rimm; Vincenzo Trischitta; Frank B Hu; Yongmei Liu; Lu Qi Journal: Hum Mol Genet Date: 2012-07-26 Impact factor: 6.150